Ji E Chang

Ji Chang

Ji E Chang

Scroll

Associate Professor of Public Health Policy and Management

Professional overview

Ji Eun Chang, Ph.D., is an Associate Professor in the Department of Public Health Policy and Management at the New York University School of Global Public Health, where she also serves as the public health policy and management concentration director for the Ph.D. program. Professor Chang uses mixed-methods research designs and draws from qualitative, quantitative, and geospatial data to demonstrate disparities and highlight barriers faced by safety net providers and underserved patients in accessing equitable care.

Professor Chang is the principal investigator of the AI4Healthy Cities Initiative in New York City, a multi-city collaboration between the Novartis Foundation, Microsoft AI4Health, and local health officials to reduce cardiovascular health inequities through big data analytics. Dr. Chang is also the co-principal investigator of an NIH NIDA-funded study to support implementing transitional opioid programs in safety net hospitals. Dr. Chang received a B.A. in Economics from the University of California at Berkeley, an M.S. in Public Policy and Management from Carnegie Mellon University, and a Ph.D. in Public Administration from New York University in 2016.

Education

BA, Economics, University of California at Berkeley, Berkeley, CA
MS, Public Policy and Management, Carnegie Mellon University, Pittsburgh, PA
PhD, Public Administration, New York University, New York, NY

Honors and awards

Governor’s Scholar (2007)
Regents and Chancellors’ Scholar (2005)

Areas of research and study

Cardiovascular Disease
Health Disparities
Health Equity
Public Health Management
Public Health Management
Safety Net Providers and Patients
Substance Use Disorders

Publications

Publications

Examining the Relationship between Local Governmental Expenditures on the Social Determinants of Health and County-Level Overdose Deaths, 2017-2020

Forging hospital and community partnerships to enable care coordination for opioid use disorder

Patient–Provider Communication for Lonely, Socially Isolated Adults in Medicare

Toward a Consensus on Strategies to Support Opioid Use Disorder Care Transitions Following Hospitalization: A Modified Delphi Process

A Year After Implementation of the Telehealth Waiver: Being Offered and Utilizing Video-Specific Telehealth Among Dual-Eligible Medicare Recipients During the COVID-19 Pandemic

Barriers and Facilitators to Establishing Partnerships for Substance Use Disorder Care Transitions Between Safety-Net Hospitals and Community-Based Organizations

Comparing Rates of Undiagnosed Hypertension and Diabetes in Patients With and Without Substance Use Disorders

Discrimination in Medical Settings across Populations: Evidence From the All of Us Research Program

Examining the relationship between social determinants of health, measures of structural racism and county-level overdose deaths from 2017–2020

Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals

Rural-urban disparities in the availability of hospital-based screening, medications for opioid use disorder, and addiction consult services

The Ecology of Economic Distress and Life Expectancy

Trends in the availability of comprehensive services within outpatient substance use treatment facilities from 2018 to 2022

An observational, sequential analysis of the relationship between local economic distress and inequities in health outcomes, clinical care, health behaviors, and social determinants of health

Assessing Differences in Social Determinants of Health Screening Rates in a Large, Urban Safety-Net Health System

Association of Medicaid expansion and 1115 waivers for substance use disorders with hospital provision of opioid use disorder services: a cross sectional study

Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings

Facilitation of team-based care to improve HTN management and outcomes: a protocol for a randomized stepped wedge trial

Factors associated with the adoption of evidence-based innovations by substance use disorder treatment organizations: A study of HIV testing

Hospital adoption of harm reduction and risk education strategies to address substance use disorders

Integrating Harm Reduction into Medical Care: Lessons from Three Models

Rural-urban disparities in health outcomes, clinical care, health behaviors, and social determinants of health and an action-oriented, dynamic tool for visualizing them

Stakeholder Perspectives on Data-Driven Solutions to Address Cardiovascular Disease and Health Equity in New York City

Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology

Substance Use Disorder Program Availability in Safety-Net and Non–Safety-Net Hospitals in the US

Contact